APA (7th ed.) Citation

DL, B., HE, B., M, M., 3rd, C. J., K, W., NS, A., . . . JJP, K. (2024). Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial. Nature medicine, 30(6), 1788. https://doi.org/10.1038/s41591-024-02890-2

Chicago Style (17th ed.) Citation

DL, Bhatt, et al. "Author Correction: The FGF21 Analog Pegozafermin in Severe Hypertriglyceridemia: A Randomized Phase 2 Trial." Nature Medicine 30, no. 6 (2024): 1788. https://doi.org/10.1038/s41591-024-02890-2.

MLA (9th ed.) Citation

DL, Bhatt, et al. "Author Correction: The FGF21 Analog Pegozafermin in Severe Hypertriglyceridemia: A Randomized Phase 2 Trial." Nature Medicine, vol. 30, no. 6, 2024, p. 1788, https://doi.org/10.1038/s41591-024-02890-2.